Efficacy of Tibolone Versus Transdermal E2/NETA on Sexual Function in Naturally Postmenopausal Women (P06089)

Inclusion Criteria: * Physically and mentally healthy postmenopausal women, \>=48 and \<=68 years of age, with an intact uterus. * Women were to suffer from decreased satisfactory sexual activity compared to younger age and sexual problems were not to be considered caused by relationship/partner problems. The decreased sexual functioning was to result in sexually related personal distress as confirmed by the FSDS (score =15). * An affirmative answer was to be given to the following questions: (a) In previous years did you find sexual activity satisfying? (b) Has there been a decline in your satisfaction with sexual activity? (c) Are you satisfied with your partner as a friend? * All subjects were to have an established sexual relationship of at least 6 months duration prior to screening. * Women were to be sexually active. * Normal mammography within 6 months prior to randomization. * Body mass index \>18 and \<=32 kg/m2. * Voluntary written informed consent Exclusion Criteria: * Any unexplained abnormal uterine bleeding * Double layer endometrial thickness \>4 mm * Tibolone or transdermal E2/NETA use within 3 months prior to screening * Progestogen implants or injections and estrogen/progestogen injectable therapy within 6 months prior to screening * Use of intra-uterine progestogen * Unsuccessful previous treatment with androgens or compounds known to enhance androgenic activity * Current successful treatment with androgens, without applying the applicable washout period…